DTaP
DTaP is a biological therapy with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Study of Concomitant Administration of the sIPV and DTaP or MMR
Fever After Simultaneous Versus Sequential Vaccination in Young Children
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP
Clinical Trials (12)
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
Study of Concomitant Administration of the sIPV and DTaP or MMR
Fever After Simultaneous Versus Sequential Vaccination in Young Children
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA
Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.
All 12 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 12